ROYCE & ASSOCIATES LP - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 24 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q3 2022$49,000
-44.3%
135,8000.0%0.00%0.0%
Q2 2022$88,000
-20.7%
135,8000.0%0.00%0.0%
Q1 2022$111,000
-69.0%
135,800
-56.8%
0.00%
-66.7%
Q4 2021$358,000
-70.9%
314,353
-36.0%
0.00%
-66.7%
Q3 2021$1,229,000
-15.8%
491,4530.0%0.01%
-10.0%
Q2 2021$1,460,000
-15.4%
491,4530.0%0.01%
-16.7%
Q1 2021$1,725,000
-26.1%
491,4530.0%0.01%
-36.8%
Q4 2020$2,334,000
-2.3%
491,4530.0%0.02%
-26.9%
Q3 2020$2,388,000
+25.8%
491,453
-15.9%
0.03%
+23.8%
Q2 2020$1,899,000
-68.4%
584,342
-50.3%
0.02%
-74.4%
Q1 2020$6,018,000
+33.1%
1,175,316
+18.5%
0.08%
+105.0%
Q4 2019$4,521,000
+20.0%
991,492
+61.1%
0.04%
+14.3%
Q3 2019$3,768,000
+31.9%
615,618
+31.2%
0.04%
+34.6%
Q2 2019$2,857,000
+9.7%
469,1530.0%0.03%
+18.2%
Q1 2019$2,604,000
-1.9%
469,1530.0%0.02%
-8.3%
Q4 2018$2,655,000
-20.8%
469,153
+47.0%
0.02%
+4.3%
Q3 2018$3,351,000
+0.8%
319,153
+6.6%
0.02%0.0%
Q2 2018$3,323,000
+92.9%
299,353
+39.0%
0.02%
+91.7%
Q1 2018$1,723,000
+105.1%
215,353
+110.3%
0.01%
+100.0%
Q4 2017$840,000
+517.6%
102,400
+367.6%
0.01%
+500.0%
Q3 2017$136,000
+3.0%
21,9000.0%0.00%0.0%
Q2 2017$132,00021,9000.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,150,925$7,826,0002.91%
New Jersey Better Educational Savings Trust 158,000$1,074,0000.69%
ARS Investment Partners, LLC 620,936$4,222,0000.65%
PERKINS CAPITAL MANAGEMENT INC 68,050$463,0000.51%
First Light Asset Management, LLC 76,302$519,0000.23%
Kovack Advisors, Inc. 33,509$228,0000.11%
WHITE PINE CAPITAL LLC 32,625$222,0000.09%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 97,823$665,0000.06%
TAURUS ASSET MANAGEMENT, LLC 17,000$116,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 107,500$731,0000.01%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders